Six Australian infectious disease ventures share $10.48 million in Biointelect funding round

August 31, 2026 Latest News Australian Biotech

This is a preview of subscriber content

Subscribe now to continue reading.

Six Australian companies developing vaccines, antiviral treatments, and vaccine-production technologies will share $10.48 million in Biointelect Venture's first funding round. …

Subscribe now to continue reading.

Latest Video

Sanofi leader urges Australia to look beyond the laboratory in building vaccine capability
August 31, 2026 - Latest News
Astellas Australia turns to rare disease leader Guillaume Pfeiffer for next chapter
August 31, 2026
A decade is more than enough - the case for term limits on advisory committees
August 31, 2026 - Latest News
Expansion opens PBS access for more with advanced cancer, but it took a long time
August 31, 2026 - Latest News
Funding brings a new targeted treatment for Australians with lupus kidney disease
August 31, 2026 - Latest News

Six Australian infectious disease ventures share $10.48 million in Biointelect funding round

This is a preview of subscriber content

Sanofi leader urges Australia to look beyond the laboratory in building vaccine capability

Astellas Australia turns to rare disease leader Guillaume Pfeiffer for next chapter

A decade is more than enough - the case for term limits on advisory committees

Expansion opens PBS access for more with advanced cancer, but it took a long time

Funding brings a new targeted treatment for Australians with lupus kidney disease

Six Australian infectious disease ventures share $10.48 million in Biointelect funding round

BLS posts record earnings as overseas expansion accelerates

Private hospitals sustain 230,000 jobs despite $756 million loss

Alterity secures option underwriting as it prepares for pivotal MSA trial

Avecho resumes pivotal insomnia trial recruitment after positive interim review

Tetratherix sends first commercial polymer shipment to United States

September agenda puts cancer drugs, RSV prevention and ADHD access in focus

Sign In

Six Australian infectious disease ventures share $10.48 million in Biointelect funding round

This is a preview of subscriber content

Latest Video

Most Read

Sanofi leader urges Australia to look beyond the laboratory in building vaccine capability

Astellas Australia turns to rare disease leader Guillaume Pfeiffer for next chapter

A decade is more than enough - the case for term limits on advisory committees

Expansion opens PBS access for more with advanced cancer, but it took a long time

Funding brings a new targeted treatment for Australians with lupus kidney disease

Follow Us

New Stories

Six Australian infectious disease ventures share $10.48 million in Biointelect funding round

BLS posts record earnings as overseas expansion accelerates

Private hospitals sustain 230,000 jobs despite $756 million loss

Alterity secures option underwriting as it prepares for pivotal MSA trial

Avecho resumes pivotal insomnia trial recruitment after positive interim review

Tetratherix sends first commercial polymer shipment to United States

September agenda puts cancer drugs, RSV prevention and ADHD access in focus